Jinding Capital is a prominent venture capital firm based in Beijing, China, founded in 2014. Specializing in industrial equity investments, the firm focuses on various sectors, including household products, food and beverage, pet care, beauty, medical services, and communications. By targeting these diverse areas, Jinding Capital aims to support innovative companies and foster growth within the Chinese market.
Huaban Biotech is dedicated to the innovative research and development of new materials for medical aesthetics.
Moyang Biotechnology
Series B in 2024
Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
AIMIRA Innovation Technology
Seed Round in 2023
AIMIRA Innovation Technology is an AI-based medical technology company that offers diagnosis, aesthetic plastic surgery, and anti-aging medicine.
Bawei
Series B in 2022
Guangdong Bawei Bio-Technology Co., Ltd., established in 2006 and based in Guangzhou, China, specializes in the manufacturing and sale of cosmetics. Originally known as Guangzhou Bawei Cosmetics Co., Ltd., the company rebranded in September 2015. Bawei operates as an original equipment manufacturer (OEM), providing services such as brand processing, custom samples, and semi-finished product supply. Their product range includes various cosmetics like natural nude makeup air cushion CC cream, sunscreen, and products tailored for men, among others. The company is also involved in product planning, formula research and development, and efficacy testing to ensure quality and innovation in its offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.